Feb 12, 2016 by Brian FeroldiWhy Intercept Pharmaceuticals Inc is Skyrocketing TodayBuyout rumors send the clinical stage biopharma's shares higher.
Feb 12, 2016 by Brian FeroldiWhy Coherus BioSciences Plunged 37% in JanuaryThe biosimilar pure play is sold off hard despite having good news to share with investors.
Feb 12, 2016 by Brian Feroldi, Sean Williams, and Andrés Cardenal3 Companies That Could Slash Their DividendsOur contributors think that investors in these stocks might soon see their quarterly payouts shrink.
Feb 12, 2016 by Brian FeroldiEylea's Slowing Sales Growth Sends Regeneron Pharmaceutical Inc.'s Shares LowerSales and profits of Regeneron's best-selling drug come up a bit short of expectations.
Feb 11, 2016 by Brian FeroldiCVS Health Inc Reports Q4 Growth and Prescribes Itself a Prosperous 2016The retail pharmacy giant reported solid fourth quarter results and predicts another year of strong growth ahead.
Feb 11, 2016 by Brian FeroldiWhy Shares of TripAdvisor Inc Are Soaring TodayAn earnings report full of good news has investors feeling bullish.
Feb 10, 2016 by Brian FeroldiWhy Retrophin Inc was Down TodayNews of an incoming competitor pushed shares lower in early trading.
Feb 10, 2016 by Brian FeroldiWhy Shire PLC Fell 15% in JanuaryNews of a monster acquisition gives investors pause.
Feb 9, 2016 by Brian FeroldiWhy Keryx Biopharmaceuticals Inc. Plunged 26% in JanuaryThe one drug biopharma got caught up in January's biotech melt down.
Feb 9, 2016 by Brian FeroldiVertex Pharmaceuticals Inc. Dropped 26% in January -- Here's WhyThe market dumped everything related to biotechnology, and Vertex got caught up in the storm.
Feb 9, 2016 by Brian FeroldiWhy MannKind Corporation Is Popping TodayNews of a definitive transition date puts investors in a good mood.
Feb 9, 2016 by Brian FeroldiWhy MannKind Corporation's Shares Plunged 31% in JanuaryIt was a crazy month for the beaten-down biotech.
Feb 8, 2016 by Brian FeroldiWhy Sarepta Therapeutics Inc. Is Down TodayNews of a pushback in its PDUFA date sends shares lower.
Feb 8, 2016 by Brian FeroldiWhy Radius Health Inc. Dropped 45% in JanuaryGood news from the clinical-stage osteoporosis specialist couldn't overcome January's biotech beat down.
Feb 8, 2016 by Brian FeroldiWhy bluebird bio Inc.'s Stock Dropped 34% in JanuaryBluebird's stock get caught up in January's biotech meltdown.
Feb 7, 2016 by Brian Feroldi3 Things to Watch When FormFactor Inc. ReportsFrom management's outlook to its share buyback activity, here are the three areas investors should pay attention to.
Feb 7, 2016 by Brian FeroldiWhy Shares of Sarepta Therapeutics Inc. Collapsed in JanuaryHarsh words from a FDA advisory committee report have investors fearing the worst.
Feb 7, 2016 by Brian FeroldiWhat to Watch When Infinera Corp. Reports EarningsFrom integration updates to margin details, here are the key areas that investors should pay attention to.
Feb 6, 2016 by Brian FeroldiLast Week's Best Healthcare ETFIt was another rough week for the healthcare sector, but this healthcare ETF performed the best.
Feb 6, 2016 by Brian FeroldiWhy Ionis Pharmaceuticals Inc Plunged 36% in JanuarySometimes bad things can happen to good companies.
